Rostec to Invest over 1 bln Rubles in Medical-Pharmaceutical Cluster in Yaroslavl Region

| By | Rostec, Russian Pharma

Ruselectronics Holding integrated with the state corporation Rostec will set up a medical pharmaceutical cluster in the Yaroslavl region under an agreement on cooperation with the Vega concern and the regional administration.

The agreement was signed by Vega General Director Vyacheslav Mikheyev and Yaroslavl Region Governor Dmitry Mironov at the St. Petersburg international economic forum, Rostec said in a statement.

Investment in the project will exceed 1 billion rubles.

The new cluster will be created in Rostov Veliky. It will manufacture hemostatic biodegradable materials with the use of Czech technologies and injection medical needles in a full-cycle mode with an annual capacity of 700 million, including semi-finished needles, dental needles and needles for vacuum blood drawing systems.

Vega (integrated with Ruselectronics) will be responsible for the centralization of clinical diagnostic laboratories in the Yaroslavl region, which will help reduce budget spending on laboratory research by at least 20%.

The new project is part of Rostec’s systemic import substitution strategy in the segment of critically important products. The work embraces a large spectrum of fields from the development of the domestic production of medical equipment and dispensable materials to the manufacturing of pharmaceutical products and vaccines entered on the national immunization schedule. It will ease Russia’s dependence on imports,

Rostec General Director Sergei Chemezov was quoted as saying.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.